The lipid soluble redox cofactor menaquinone is an essential component of the mycobacterial respiratory chain and selective inhibitors of menaquinone biosynthesis are promising lead compounds for the treatment of latent tuberculosis (TB) infections. Menaquinone is synthesized from chorismate by the action of at least 7 enzymes including 1,4‐dihydroxynaphthoyl‐CoA synthase (MenB), which catalyzes an intramolecular Claisen (Dieckmann) condensation to form 1,4‐dihydroxynaphthoyl‐CoA from O‐succinylbenzoyl‐CoA. Currently we are comparing and contrasting the mechanism of the TB MenB enzyme with that of MenB from E. coli as well as with other members of the crotonase superfamily including 2‐ketocyclohexanecarboxyl‐CoA hydrolase (BadI), which catalyzes a retroDieckmann reaction. Crystallographic and kinetic data indicate that conserved catalytic residues play similar roles in the reactions catalyzed by MenB and BadI. However, the studies also suggest subtle differences in the mechanisms of the reactions catalyzed by the TB and E. coli MenB enzymes. In separate studies we recently identified several μM inhibitors of MenB using high‐throughput screening at the NRPB. These compounds are promising leads for developing novel inhibitors of menaquinone biosynthesis.
Read full abstract